Development and Validation of a Pragmatic Electronic Phenotype for CKD
- 12 August 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 14 (9) , 1306-1314
Abstract
Background and objectives: Poor identification of individuals with CKD is a major barrier to research and appropriate clinical management of the disease. We aimed to develop and validate a pragmatic electronic (e-) phenotype to identify patients likely to have CKD. Design, setting, participants, & measurements: The e-phenotype was developed by an expert working group and implemented among adults receiving in- or outpatient care at five healthcare organizations. To determine urine albumin (UA) dipstick cutoffs for CKD to enable use in the e-phenotype when lacking urine albumin-to-creatinine ratio (UACR), we compared same day UACR and UA results at four sites. A sample of patients, spanning no CKD to ESKD, was randomly selected at four sites for validation via blinded chart review. Results: The CKD e-phenotype was defined as most recent eGFR 2 with at least one value 90 days prior and/or a UACR of ≥30 mg/g in the most recent test with at least one positive value >90 days prior. Dialysis and transplant were identified using diagnosis codes. In absence of UACR, a sensitive CKD definition would consider negative UA results as normal to mildly increased (KDIGO A1), trace to 1+ as moderately increased (KDIGO A2), and ≥2+ as severely increased (KDIGO A3). Sensitivity, specificity, and diagnostic accuracy of the CKD e-phenotype were 99%, 99%, and 98%, respectively. For dialysis sensitivity was 94% and specificity was 89%. For transplant, sensitivity was 97% and specificity was 91%. Conclusions: The CKD e-phenotype provides a pragmatic and accurate method for EHR-based identification of patients likely to have CKD.Keywords
Funding Information
- National Institute of General Medical Sciences
- National Institutes of Health (U54-GM104941, P20 GM103446)
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (UG3DK114926)
- National Human Genome Research Institute (U01HG8680)
- National Center for Advancing Translational Sciences
- National Institutes of Health (UL1 TR001872)
This publication has 10 references indexed in Scilit:
- Variation in Patients’ Awareness of CKD according to How They Are AskedClinical Journal of the American Society of Nephrology, 2016
- CKD as a Model for Improving Chronic Disease Care through Electronic Health RecordsClinical Journal of the American Society of Nephrology, 2015
- Development and validation of an electronic phenotyping algorithm for chronic kidney disease.2014
- State of the Art for Measurement of Urine Albumin: Comparison of Routine Measurement Procedures to Isotope Dilution Tandem Mass SpectrometryClinical Chemistry, 2014
- NoticeKidney International Supplements, 2013
- Validation of CKD and Related Conditions in Existing Data Sets: A Systematic ReviewAmerican Journal of Kidney Diseases, 2011
- Symptom Burden, Depression, and Quality of Life in Chronic and End-Stage Kidney DiseaseClinical Journal of the American Society of Nephrology, 2009
- A New Equation to Estimate Glomerular Filtration RateAnnals of Internal Medicine, 2009
- Creatinine measurement: state of the art in accuracy and interlaboratory harmonization.Archives of Pathology & Laboratory Medicine, 2005
- Creatinine Measurement: State of the Art in Accuracy and Interlaboratory HarmonizationArchives of Pathology & Laboratory Medicine, 2005